Ajinomoto Co Inc, the Tokyo-listed food seasoning giant that holds a controlling stake in Ajinomoto Malaysia, has announced plans to take the monosodium glutamate producer private in a transaction valued at RM603.4 million. The move represents a significant delisting milestone for one of Malaysia's oldest food manufacturing companies and signals a strategic shift toward unlisted operations that offer greater operational autonomy to the Japanese multinational.
Under the proposed privatisation structure, minority shareholders owning 49.62% of Ajinomoto Malaysia will receive a capital repayment of RM20 per share in cash, representing the total consideration of RM603.4 million. This valuation reflects a substantial premium to recent market prices, standing at 31.58% above the closing price of RM15.20 recorded on June 19, 2026, the last trading day before the suspension. The offer also represents gains of between 30.68% and 49.93% compared to the five-day and one-year volume weighted average prices respectively, providing a meaningful exit opportunity for long-held positions.
Ajinomoto Co Inc justified the privatisation primarily on the grounds of improving liquidity access for minority investors who have historically struggled to realise their shareholdings. The company noted that trading activity in Ajinomoto Malaysia shares has remained persistently thin, with an average daily volume of approximately 38,715 shares recorded over the past five years. This chronic lack of liquidity has created a fundamental disconnect between share ownership and market tradability, effectively trapping minority shareholders' capital in a security that rarely changes hands.
Beyond addressing shareholder liquidity concerns, the privatisation will enable Ajinomoto Malaysia to streamline its corporate structure and significantly reduce the regulatory compliance burden associated with maintaining a public listing on Bursa Malaysia Securities. The company will no longer need to allocate management bandwidth to satisfy continuous disclosure obligations, financial reporting requirements, and audit protocols mandated for listed entities. These operational benefits extend to eliminating the substantial costs associated with listing maintenance, including regulatory fees and corporate governance infrastructure.
The transaction mechanism involves a sophisticated capital restructuring that uses retained earnings to facilitate the delisting. Ajinomoto Malaysia will execute a bonus share issue of 571.11 million shares, capitalising RM571.1 million from accumulated reserves. This bonus capitalisation creates sufficient shares to account for the capital repayment being distributed to minority shareholders. Following the share distribution and subsequent cancellation of all minority-held shares and bonus shares, Ajinomoto Co Inc will hold 100% equity ownership of the subsidiary, consolidating complete control.
Significantly, Ajinomoto Malaysia has not accessed the capital markets for equity fundraising for more than a decade, rendering the public listing increasingly anachronistic from a financing perspective. The company operates with a current issued share capital of RM65.1 million comprising 60.8 million shares, figures that have remained static as the business has matured and evolved without requiring fresh equity capital. This extended period without capital market activity underscores that the public listing no longer serves a functional financing purpose for the parent company's operations.
For Malaysian investors and the broader regional investment community, the transaction presents both opportunities and implications. The premium offer price provides minority shareholders with an attractive exit opportunity at valuations superior to recent trading ranges, recognising that the shares have faced persistent valuation discounts due to illiquidity. However, the delisting will eliminate Ajinomoto Malaysia as an investment vehicle for Malaysian portfolio managers and retail investors seeking exposure to the monosodium glutamate and food ingredients sector. This loss of a publicly-listed seasoning manufacturer represents a minor but incremental contraction of Malaysia's listed equity universe.
The privatisation reflects broader trends among multinational corporations operating in Southeast Asia, where controlling shareholders increasingly reassess the strategic value of maintaining minority-owned public listings. Where foreign parents already hold majority control and the subsidiary generates stable operational cash flows rather than requiring external capital, the burdens of public company compliance often outweigh the benefits of maintaining listing status. Ajinomoto Co Inc's decision exemplifies this calculus, prioritising operational flexibility and cost reduction over maintaining public equity market exposure.
From a Malaysian regulatory and capital market perspective, the transaction underwent standard delisting procedures administered by Bursa Malaysia. Share trading was suspended on June 22, 2026, with resumption scheduled for June 23 to allow completion of formal regulatory notifications and shareholder communications. The privatisation represents a normal course exercise of majority shareholder prerogatives to restructure subsidiary ownership when minority stakes remain inactive and illiquid.
The move consolidates Ajinomoto Co Inc's direct operational control over its Malaysian monosodium glutamate manufacturing and food seasoning operations, enabling more streamlined strategic decision-making without navigating minority shareholder considerations. The Japanese company retains full discretion over capital allocation, dividend policy, and business expansion strategies without requirement for board approval processes that public company status demands.
For employees and supply chain partners of Ajinomoto Malaysia, the privatisation should produce no material operational changes, as the subsidiary will continue manufacturing and distributing monosodium glutamate and related seasonings under the Ajinomoto brand. The efficiency gains from delisting derive primarily from administrative and governance streamlining rather than operational restructuring.
The transaction underscores how Malaysian public companies, particularly subsidiaries of foreign multinationals, must continuously justify their listed status through utility and benefit demonstration. When liquidity dries up and capital markets become irrelevant to funding operations, delisting and privatisation increasingly become the rational corporate outcome, particularly for mature, stable businesses operated by strong parent companies with sufficient financial capacity to absorb the subsidiary entirely.
